As of 31 Dec 2025, 1 institutional investors reported holding 10,000 shares of SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 10,000 | $260 | +$260 | $0.03 | 1 |
| 2024 Q3 | 0 | $0 | -$223,879 | $0.03 | 0 |
| 2024 Q2 | 2,684,340 | $225,832 | -$14,216 | $0.08 | 29 |
| 2024 Q1 | 2,687,318 | $195,999 | -$620 | $0.08 | 26 |
| 2023 Q4 | 2,695,707 | $78,024 | -$17,807 | $0.03 | 25 |
| 2023 Q3 | 3,346,307 | $112,618 | +$3,024 | $0.03 | 33 |
| 2023 Q2 | 3,240,305 | $275,327 | -$7,938 | $0.09 | 31 |
| 2023 Q1 | 3,153,103 | $281,556 | +$9,328 | $0.09 | 30 |
| 2022 Q4 | 2,931,366 | $329,993 | -$12,363 | $0.11 | 27 |
| 2022 Q3 | 2,880,935 | $205,000 | -$36,572 | $0.07 | 23 |
| 2022 Q2 | 3,498,975 | $358,000 | -$138,524 | $0.10 | 29 |
| 2022 Q1 | 3,522,155 | $806,000 | -$17,530 | $0.24 | 31 |
| 2021 Q4 | 3,030,060 | $1,684,000 | +$37,519 | $0.56 | 25 |
| 2021 Q3 | 2,844,116 | $1,710,000 | +$295,165 | $0.60 | 24 |
| 2021 Q2 | 2,349,841 | $1,798,000 | +$1,684,000 | $0.76 | 17 |